Elevated blood pressure is not related to saliva flow in patients with Sjögren's syndrome

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 94, Issue 2, 2002, Pages 179-183

  Sankar, Vidya ^a   Brennan, Michael T ^b   Radfar, Lida ^a   Leakan, Rose Anne ^c   Pillemer, Stanley R ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; SECRETORY IMMUNOGLOBULIN; SS A ANTIBODIES; SS B ANTIBODIES; SS-A ANTIBODIES; SS-B ANTIBODIES;

ADULT; ARTICLE; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; CLASSIFICATION; COMPARATIVE STUDY; DIASTOLE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SALIVA; SECRETION; SJOEGREN SYNDROME; STATISTICS; SYSTOLE; XEROPHTHALMIA; XEROSTOMIA;

ADULT; ANTIBODIES, ANTINUCLEAR; BLOOD PRESSURE; BLOOD SEDIMENTATION; CHI-SQUARE DISTRIBUTION; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; SALIVA; SECRETORY RATE; SJOGREN'S SYNDROME; STATISTICS; SYSTOLE; XEROPHTHALMIA; XEROSTOMIA;

EID: 0036675027     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2002.123861     Document Type: Article

References (33)

1. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine 1965;44:187-231.
2. Andonopoulos AP, Christodoulou J, Ballas C, Bounas A, Alexopoulos D. Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study. J Rheumatol 1998;25:2385-8.
3. Wright RA, Grant IA, Low PA. Autonomic neuropathy associated with sicca complex. J Auton Nerv Syst 1999;75:70-6.
4. Mandl T, Jacobsson L, Lilja B, Sundkvist G, Manthorpe R. Disturbances of autonomic nervous function in primary Sjögren's syndrome. Scand J Rheumatol 1997;26:401-6.
5. Ramos-Remus C, Suarez-Almazor M, Russel AS. Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome. Clin Exp Rheum 1994;12:375-80.
6. Barendregt PJ, van Den Meiracker AH, Markusse HM, Tulen JH, Boomsma F, van Der Heijde GL, et al. Parasympathetic failure does not contribute to ocular dryness in primary Sjögren's syndrome. Ann Rheum Dis 1999;58:746-50.
7. Koski H, Janin A, Humphreys-Beher MG, Sorsa T, Malmstrom M, Konttinen YT. Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren's syndrome. Clin Exp Rheumatol 2001;19:131-7.
8. Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 1998;87:309-13.
9. Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren's syndrome. Invest Ophthalmol Vis Sci 2001;42:321-7.
10. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000;43:1647-54.
11. Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda ES. Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren's syndrome antibodies. Clin Immunol 1999;90:190-5.
12. Bacman SR, Berra A, Sterin-Borda L, Borda ES. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 1998;17:1135-42.
13. Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E. Antibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Ophthalmol Vis Sci 1998;39:151-6.
14. Borda E, Camusso JJ, Perez Leiros C, Bacman S, Hubscher O, Arana R, et al. Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjogren's syndrome. Mol Cell Biochem 1996;163:335-41.
15. Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 1996;104:454-9.
16. Baum BJ. Principles of saliva secretion. Ann N Y Acad Sci 1993;694:17-23.
17. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987;80:812-7.
18. Rahn KH, van Baak M, van Hooff M, Schols M. Studies on salivary flow in borderline hypertension. J Hypertens Suppl 1983;1:77-8.
19. Ben-Aryeh H, Schiller M, Shasha S, Szargel R, Gutman D. Salivary composition in patients with essential hypertension and the effect of Pindolol. J Oral Med 1981;36:76-8.
20. Van Hooff M, Van Baak M, Schols M, Rahn KH. Studies of salivary flow in borderline hypertension: effects of drugs action on structures innervated by the autonomic nervous system. Clin Sci 1984;66:599-604.
21. Böhm R, van Baak M, van Hooff M, Moy J, Rahn KH. Salivary flow in borderline hypertension. Klin Wochenschr 1985;63(Suppl III):154-6.
22. Streckfus CF. Salivary function and hypertension: a review of the literature and a case report. JADA 1995;126:1012-7.
23. Julius S, Esler M. Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol 1975;36:285-696.
24. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996;55:116-21.
25. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
26. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985;110:519-25.
27. Atkinson JC, Fox PC. Salivary gland dysfunction. Clin Geriatr Med 1992;8:499-511.
28. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjogren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
29. Niedermeier W, Dreizen S, Stone R, Spies T. Sodium and potassium concentrations in the saliva of normotensive and hypertensive subjects. Oral Surg Oral Med Oral Pathol 1956;9:426-31.
30. Streckfus CF, Wu AJ, Ship JA, Brown LJ. Stimulated parotid salivary flow rates in normotensive, hypertensive, and hydrochlorothiazide-medicated. J Oral Pathol Med 1994;23:280-3.
31. Streckfus CF, Wu AJ, Ship JA, Brown LJ. A comparison of stimulated parotid salivary gland flow rates in normotensive and hypertensive persons. Oral Surg Oral Med Oral Pathol 1994;77:615-9.
32. Nederfors T, Dahlof C. Effects on salivary flow rate and composition of withdrawal of and re-exposure to the beta1-selective antagonist metoprolol in a hypertensive patient population. Eur J Oral Sci 1996;104:262-8.
33. Raczak G, La Rovere MT, Mortara A, Assandri J, Prpa A, Pinna GD, et al. Arterial baroreflex modulation of heart rate in patients early after heart transplantation: lack of parasympathetic reinnervation. J Heart Lung Transplant 1999;18:399-406.